Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in ZYME — Zymeworks Inc.

CIK 820027 MINNEAPOLIS, MN
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,150,380
+$291,863 QoQ
Shares Held
82,264
+10.8% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 202 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. ZYME ranks #128 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in ZYME

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,150,380 82,264
2026-03-31 $1,858,517 74,222
2025-12-31 $2,979,002 113,141
2025-09-30 $1,296,849 75,928
2024-12-31 $1,779,140 121,526
2024-09-30 $1,723,441 137,326
2024-06-30 $1,168,644 137,326
2024-03-31 $1,491,662 141,793
2023-12-31 $1,277,201 122,926